Horizon Therapeutics Patents – Key Insights and Stats

Horizon Therapeutics has a total of 1331 patents globally, out of which 582 have been granted. Of these 1331 patents, more than 47% patents are active. The United States of America is where Horizon Therapeutics has filed the maximum number of patents, followed by Japan and Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Horizon Therapeutics.

Horizon Therapeutics was founded in the year 2005. The Company is a biotechnology company. The Company focuses on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. As of March 2023, the market cap of Horizon Therapeutics is $25.14 Billion.

Do read about some of the most popular patents of Horizon Therapeutics which have been covered by us in this article and also you can find Horizon Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Horizon Therapeutics patent portfolio.

How many patents does the founder and the CEO of Horizon Therapeutics have?

The founder George F. Tidmarsh has 2 patents and CEO Timothy P Walbert has 0 patent.

How many patents does Horizon Therapeutics have?

Horizon Therapeutics has a total of 1331 patents globally. These patents belong to 220 unique patent families. Out of 1331 patents, 634 patents are active.

How Many Patents did Horizon Therapeutics File Every Year?

Horizon Therapeutics Patent Filling Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantHorizon Therapeutics Applications FiledHorizon Therapeutics Patents Granted
20233
20222425
20214834
20205231
20194441
20184157
20177560
20168849
20155240
20147351
20134034
20127540

How many Horizon Therapeutics patents are Alive/Dead?

Horizon Therapeutics Patent Portfolio

How Many Patents did Horizon Therapeutics File in Different Countries?

Horizon Therapeutics Worldwide Patent Filling

Countries in which Horizon Therapeutics Filed Patents

CountryPatents
United States Of America270
Japan93
Europe84
Australia63
Canada57
Hong Kong (S.A.R.)47
Korea (South)46
Israel43
Germany36
Singapore34
China34
Mexico30
Spain30
Brazil29
Poland26
India25
Hungary22
Denmark21
New Zealand20
South Africa19
Portugal19
Taiwan18
Russia16
Norway16
Lithuania14
Chile13
Argentina12
Slovenia12
Croatia10
Cyprus9
Austria9
Albania7
Indonesia6
Serbia6
Malta6
Viet Nam5
Philippines5
Malaysia5
Czech Republic4
Eurasia3
Gulf Cooperation Council3
Ukraine2
Tunisia2
Italy2
Ireland1
Colombia1
Netherlands1
Luxembourg1
Turkey1
Cuba1
Nicaragua1
Africa1
Ecuador1
Africa1
Montenegro1
Macao1
Morocco1

Where are Research Centres of Horizon Therapeutics Patents Located?

R&D Centers of Horizon Therapeutics

10 Best Horizon Therapeutics Patents

US20030129186A1 is the most popular patent in the Horizon Therapeutics portfolio. It has received 490 citations so far from companies like Medtronic, Angiochem and Genentech.

Below is the list of 10 most cited patents of Horizon Therapeutics:

Publication NumberCitation Count
US20030129186A1490
US20050026823A1116
US20070154542A198
US9393208B284
US9220698B284
US9801824B281
US8945621B281
WO2005079789A171
US6689753B156
US20080021078A145

How many inventions of other companies were rejected due to Horizon Therapeutics patents?

The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Horizon Therapeutics invention. They couldn’t because Horizon Therapeutics had protected those before them.

Examiners at the USPTO referred 54 Horizon Therapeutics patents in 317 rejections (35 USC § 102 or 35 USC § 103 types).

The top citing companies in the Horizon Therapeutics patent portfolio are Citibank Na, Horizon Orphan and Horizon Medicines.

List of the Companies whose Patents were rejected citing Horizon Therapeutics –

CompanyNumber of Patent Applications that faced Rejection Citing Horizon Therapeutics PatentsNumber of Rejections (102 & 103)
Citibank Na1522
Horizon Orphan1563
Horizon Medicines828
Schabar Research56
Medimmune411
National Institutes Of Health414
Annovis Bio411
Qr Pharma312
Sanofi37
Angiochem38

Count of 102 and 103 Type Rejections based on Horizon Therapeutics Patents

Top Horizon Therapeutics Patents used in Rejecting Most Patent Applications

Patent NumberCount of Rejected Applications
US7838532B215
US8642012B210
US20070154542A19
US8323653B28
US20070043096A18
US20080021078A16
US8546423B25
US7700554B25
US7569544B25
US6590074B14
US8440632B24
US20080021083A14
US7786162B23
US8815838B23
US7153882B23

What Percentage of Horizon Therapeutics US Patent Applications were Granted?

Horizon Therapeutics (Excluding its subsidiaries) has filed 101 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 53 have been granted leading to a grant rate of 57.61%.

Below are the key stats of Horizon Therapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Horizon Therapeutics?

Law FirmTotal ApplicationsSuccess Rate
Global Patent Group3663.89%
Global Patent Group3345.45%
Cooley Llp Horizon Therapeutics1185.71%
Foley & Lardner620.00%
Cooley3100.00%
Kilpatrick Townsend & Stockton30.00%
Mintz Levin3100.00%
Horizon Therapeutics2100.00%
David J Brezner10%
Heller Ehrman10%

What are Horizon Therapeutics key innovation segments?

What Technologies are Covered by Horizon Therapeutics?

The chart below distributes patents filed by Horizon Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Horizon Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Horizon Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Horizon Therapeutics?

Table of Content

Insights you may find interesting

Related Articles

Ufraction8 Patents – Insights & Stats (Updated 2024)

Ufraction8 has a total of 16 patents globally, out of which 7 have been granted. Of these 16 patents, more than 87% patents are active. Parallelly, United Kingdom seems to be the main focused R&D centre and also is the origin country of Ufraction8. Ufraction8 was founded in the year

Read More »

Aizant Patents – Insights & Stats (Updated 2024)

Aizant has a total of 64 patents globally, out of which 8 have been granted. Of these 64 patents, more than 45% patents are active. India is where Aizant has filed the maximum number of patents, followed by United States of America and Canada. Parallelly, India seems to be the

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.